Basal insulin ameliorates post-breakfast hyperglycemia via suppression of post-breakfast proinsulin/C-peptide ratio and fasting serum free fatty acid levels in patients with type 2 diabetes.

Ogiso, Kazuma; Koriyama, Nobuyuki; Obo, Takahiko; Tokito, Akinori; Nishio, Yoshihiko

Ogiso, Kazuma; Koriyama, Nobuyuki; Obo, Takahiko; Tokito, Akinori; Nishio, Yoshihiko.

Afiliación

Ogiso K; Department of Diabetes and Endocrine Medicine, National Hospital Organization Kagoshima Medical Center, 8-1 Shiroyama-cho, Kagoshima, 892-0853 Japan.
Koriyama N; Department of Diabetes and Endocrine Medicine, Kagoshima University Graduate School of Medical and Dental Science, 8-35-1 Sakuragaoka, Kagoshima, 890-8520 Japan.
Obo T; Department of Diabetes and Endocrine Medicine, National Hospital Organization Kagoshima Medical Center, 8-1 Shiroyama-cho, Kagoshima, 892-0853 Japan.
Tokito A; Department of Diabetes and Endocrine Medicine, National Hospital Organization Kagoshima Medical Center, 8-1 Shiroyama-cho, Kagoshima, 892-0853 Japan.
Nishio Y; Department of Diabetes and Endocrine Medicine, Kagoshima University Graduate School of Medical and Dental Science, 8-35-1 Sakuragaoka, Kagoshima, 890-8520 Japan.

Diabetol Int ; 12(2): 161-170, 2021 Apr.

Article en En | MEDLINE | ID: mdl-33786271

Palabras clave

Basal insulin; Degludec; Free fatty acid; Glucose spike; Postprandial hyperglycemia; Proinsulin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diabetol Int Año: 2021 Tipo del documento: Article Pais de publicación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google